"Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy” of #Hydroxychloroquine and #Azithromycin used EARLY for #COVID19, concludes Yale Professor of Epidemiology Dr. Harvey Risch, MD, PhDhttps://t.co/gK6DbRlzxX

— Kulvinder Kaur MD (@dockaurG) May 27, 2020